IMB Dx, Inc. (KOSDAQ:461030)
South Korea · Delayed Price · Currency is KRW 7,130.00
0.00 (0.00%)
Apr 29, 2026, 12:10 PM KST
IMB Dx Market Cap
IMB Dx has a market cap or net worth of 99.95 billion as of April 28, 2026. Its market cap has decreased by -22.42% in one year.
Market Cap
99.95B
Enterprise Value
79.71B
Revenue
5.33B
Ranking
n/a
PE Ratio
n/a
Stock Price
7,130.00
Market Cap Chart
Since April 3, 2024, IMB Dx's market cap has decreased from 503.73B to 99.95B, a decrease of -80.16%. That is a compound annual growth rate of -54.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 99.95B | -27.91% |
| Dec 30, 2025 | 138.64B | -7.14% |
| Dec 30, 2024 | 149.29B | -70.36% |
| Apr 3, 2024 | 503.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genexine | 261.05B |
| MedPacto | 185.09B |
| Macrogen | 184.85B |
| ENCell | 181.64B |
| Vaxcell-Bio Therapeutics | 181.17B |
| Amicogen | 134.78B |
| iNtRON Biotechnology | 122.98B |
| Oncocross | 107.81B |